Clinical Trials

Ongoing clinical trials in molecular imaging and radiotheranostics. Sorted by date of last update.

Title Phase Last Update

ONC-392 Plus Lutetium Lu-177 Vipivotide Tetraxetan in Patients with mCRPC (PRESERVE-006)

Phase 1

Last update: May 22

Phase 1 May 22

MANDARIN (S6371)

Phase 3

Last update: May 22

Phase 3 May 22

Comparing the Radiopharmaceutical Drug, [Lu-177]Lu-DOTATATE, to Standard of Care Treatment for Patients with Meningioma That Has Come Back After Prior Treatment (MOMENTUM-1)

Phase 2

Last update: May 22

Phase 2 May 22

Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients with Newly Diagnosed Large B-Cell Lymphoma

Phase 2

Last update: May 22

Phase 2 May 22

A Dose Finding Study of [Lu-177]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination with Standard of Care and in Recurrent Glioblastoma as a Single Agent.

Phase 1

Last update: May 22

Phase 1 May 22

Open-label Study Comparing AAA817 versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [Lu-177]Lu-PSMA Targeted Therapy (PSMAcTION)

Phase 2

Last update: May 22

Phase 2 May 22

Lu-177-DOTA-EB-TATE in Adult Patients with Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer

Phase 1

Last update: May 22

Phase 1 May 22

Phase II Lu-177-DOTATATE Study in Metastatic NPC with a Safety Run-in (SG-AAA-II-01)

Phase 2

Last update: May 22

Phase 2 May 22

Lu-177-DOTATATE (Lutathera) in Combination with Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

Phase 1

Last update: May 22

Phase 1 May 22

Radioembolization for HCC Patients with Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)

N/A

Last update: May 22

N/A May 22